ID24870A - Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi - Google Patents

Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Info

Publication number
ID24870A
ID24870A IDW20000183A ID20000183A ID24870A ID 24870 A ID24870 A ID 24870A ID W20000183 A IDW20000183 A ID W20000183A ID 20000183 A ID20000183 A ID 20000183A ID 24870 A ID24870 A ID 24870A
Authority
ID
Indonesia
Prior art keywords
salt
physiology
complexes
accepted
vanadium compounds
Prior art date
Application number
IDW20000183A
Other languages
English (en)
Indonesian (id)
Inventor
Conradus Ghosal Gho
Original Assignee
Gho St Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gho St Holding Bv filed Critical Gho St Holding Bv
Publication of ID24870A publication Critical patent/ID24870A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000183A 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi ID24870A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1006681A NL1006681C2 (nl) 1997-07-29 1997-07-29 Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Publications (1)

Publication Number Publication Date
ID24870A true ID24870A (id) 2000-08-31

Family

ID=19765422

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000183A ID24870A (id) 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Country Status (22)

Country Link
US (2) US6579540B1 (cs)
EP (1) EP1001792B1 (cs)
JP (1) JP2001511454A (cs)
CN (1) CN1104244C (cs)
AT (1) ATE253373T1 (cs)
AU (1) AU738701B2 (cs)
BR (1) BR9811298A (cs)
CA (1) CA2298645C (cs)
CZ (1) CZ299716B6 (cs)
DE (1) DE69819514T2 (cs)
DK (1) DK1001792T3 (cs)
EA (1) EA002574B1 (cs)
ES (1) ES2207851T3 (cs)
ID (1) ID24870A (cs)
IL (2) IL134259A0 (cs)
NL (1) NL1006681C2 (cs)
NO (1) NO20000446L (cs)
NZ (1) NZ502613A (cs)
PL (1) PL338415A1 (cs)
PT (1) PT1001792E (cs)
TR (1) TR200000349T2 (cs)
WO (1) WO1999006056A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.
US8192994B2 (en) * 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
AU1898700A (en) * 1999-12-20 2001-07-03 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
EP2275560A3 (en) 2007-01-31 2012-01-25 BASF Plant Science GmbH Trangenic plants wherein the transgene is a memeber of the REMORIN gene family or a consensus sequence thereof having enhanced yield-related traits and a method for making the same
MX2009011716A (es) 2007-05-03 2009-12-11 Basf Plant Science Gmbh Plantas con rasgos mejorados relacionados con el rendimiento y un metodo para producirlas.
US8697947B2 (en) 2007-07-20 2014-04-15 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
BRPI0818482A2 (pt) 2007-10-29 2014-10-07 Basf Plant Science Gmbh Método para intensificar as características relacionadas ao redimento, constructo, uso de um constructo, planta , parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíves de uma planta, produtos, e, uso de um ácido nucleico
AU2009243552A1 (en) 2008-05-05 2009-11-12 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
US20100078320A1 (en) * 2008-09-26 2010-04-01 Applied Materials, Inc. Microwave plasma containment shield shaping
BR112012017535A2 (pt) 2010-01-15 2019-09-24 Of Medicine And Dentistry Of New Jersey University uso de compostos de vanádio para cicatrização de osso
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
JP5992917B2 (ja) 2010-12-10 2016-09-14 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー インスリン疑似剤コンポジットで被覆される埋め込み型デバイスおよびその方法
BR112013022907A2 (pt) 2011-03-07 2016-09-13 Cfm Pharma Holding Bv composição farmacêutica
US9931348B2 (en) * 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
NL2010222C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells.
NL2019605B1 (en) * 2017-09-22 2019-03-28 Cfm Pharma Holding B V Vanadyl and vanadate for use in reducing stress-induced metabolic derangement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5448490A (en) * 1989-04-24 1990-11-16 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
US5565491A (en) 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Also Published As

Publication number Publication date
EA200000176A1 (ru) 2000-10-30
AU738701B2 (en) 2001-09-27
EA002574B1 (ru) 2002-06-27
NL1006681C2 (nl) 1999-02-08
DE69819514T2 (de) 2004-09-23
TR200000349T2 (tr) 2000-09-21
PL338415A1 (en) 2000-11-06
CZ299716B6 (cs) 2008-10-29
ES2207851T3 (es) 2004-06-01
NO20000446L (no) 2000-03-24
NZ502613A (en) 2001-08-31
EP1001792B1 (en) 2003-11-05
CN1270525A (zh) 2000-10-18
BR9811298A (pt) 2000-08-29
ATE253373T1 (de) 2003-11-15
US6579540B1 (en) 2003-06-17
DE69819514D1 (de) 2003-12-11
IL134259A0 (en) 2001-04-30
AU8650598A (en) 1999-02-22
JP2001511454A (ja) 2001-08-14
IL134259A (en) 2010-02-17
PT1001792E (pt) 2004-03-31
EP1001792A1 (en) 2000-05-24
CZ2000326A3 (cs) 2000-07-12
WO1999006056A1 (en) 1999-02-11
DK1001792T3 (da) 2004-01-19
CA2298645C (en) 2004-05-18
US20030211170A1 (en) 2003-11-13
CN1104244C (zh) 2003-04-02
CA2298645A1 (en) 1999-02-11
NO20000446D0 (no) 2000-01-28

Similar Documents

Publication Publication Date Title
ID24870A (id) Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi
NZ502280A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
CA2385755A1 (en) Prevention of colorectal cancer
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
GEP20043231B (en) Resorcinol Composition
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
MY143194A (en) Topical pharmaceutical compositions for healing wounds
RU94045140A (ru) Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний
WO2001045717A3 (en) Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
EP1714661A3 (en) Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions